OABI logo

OmniAb (OABI) Company Overview

Profile

Full Name:

OmniAb, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 30, 2021

Indexes:

Not included

Description:

OmniAb (OABI) is a biotechnology company that focuses on developing and providing innovative antibody discovery solutions. They use advanced technologies to create high-quality antibodies for research and therapeutic applications, helping scientists and companies in drug development and disease treatment.

Key Details

Price

$3.65

Annual Revenue

$34.16 M(-42.17% YoY)

Annual EPS

-$0.51(-96.15% YoY)

Annual ROE

-15.43%

Beta

1.08

Events Calendar

Earnings

Next earnings date:

Mar 20, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 20, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 14, 24 HC Wainwright & Co.
Buy
Nov 14, 24 Benchmark
Buy
Aug 19, 24 Benchmark
Buy
Aug 16, 24 RBC Capital
Outperform
Aug 12, 24 HC Wainwright & Co.
Buy
May 14, 24 Benchmark
Buy
Mar 26, 24 Truist Securities
Buy
Mar 22, 24 Benchmark
Buy
Mar 21, 24 RBC Capital
Outperform
Mar 21, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for OmniAb?
  • Does OmniAb pay dividends?
  • What sector is OmniAb in?
  • What industry is OmniAb in?
  • What country is OmniAb based in?
  • When did OmniAb go public?
  • Is OmniAb in the S&P 500?
  • Is OmniAb in the NASDAQ 100?
  • Is OmniAb in the Dow Jones?
  • When was OmniAb's last earnings report?
  • When does OmniAb report earnings?
  • Should I buy OmniAb stock now?

What is the ticker symbol for OmniAb?

The ticker symbol for OmniAb is NASDAQ:OABI

Does OmniAb pay dividends?

No, OmniAb does not pay dividends

What sector is OmniAb in?

OmniAb is in the Healthcare sector

What industry is OmniAb in?

OmniAb is in the Biotechnology industry

What country is OmniAb based in?

OmniAb is headquartered in United States

When did OmniAb go public?

OmniAb's initial public offering (IPO) was on September 30, 2021

Is OmniAb in the S&P 500?

No, OmniAb is not included in the S&P 500 index

Is OmniAb in the NASDAQ 100?

No, OmniAb is not included in the NASDAQ 100 index

Is OmniAb in the Dow Jones?

No, OmniAb is not included in the Dow Jones index

When was OmniAb's last earnings report?

OmniAb's most recent earnings report was on Nov 12, 2024

When does OmniAb report earnings?

The next expected earnings date for OmniAb is Mar 20, 2025

Should I buy OmniAb stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions